STOCK TITAN

Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Vireo Growth (OTCQX: VREOF) will release third fiscal quarter results for the period ended September 30, 2025 on Wednesday, November 12, 2025 before market open.

Management will host a conference call the same day at 8:30 a.m. ET (7:30 a.m. CT). Dial-in numbers: 1-800-715-9871 (US/Canada toll-free) or 1-646-307-1963 (international toll). Conference ID: 7974705. A live audio webcast will be available in the Events & Presentations section of the company investor relations site and at https://events.q4inc.com/attendee/235390523.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+5.93% News Effect

On the day this news was published, VREOF gained 5.93%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its third fiscal quarter ended September 30, 2025 on Wednesday, November 12, 2025, before the market opens.

Vireo Growth management will host a conference call with the investment community that same day, Wednesday, November 12, 2025, at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 7974705.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link:
https://events.q4inc.com/attendee/235390523.

About Vireo Growth Inc.

Vireo was founded in 2014 as a pioneering medical cannabis company. Vireo is building a disciplined, strategically aligned, and execution-focused platform in the industry. This strategy drives our intense local market focus while leveraging the strength of a national portfolio. We are committed to hiring industry leaders and deploying capital and talent where we believe it will drive the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it serves. For more information about Vireo, visit www.vireogrowth.com.

Contact Information

Joe Duxbury
Chief Accounting Officer
investor@vireogrowth.com
(612) 314-8995


FAQ

When will Vireo Growth (VREOF) release Q3 2025 results?

Vireo Growth will release Q3 2025 results on Wednesday, November 12, 2025 before market open.

What time is the Vireo Growth (VREOF) Q3 2025 conference call?

The conference call is scheduled for 8:30 a.m. ET (7:30 a.m. CT) on November 12, 2025.

How can I join the Vireo Growth (VREOF) November 12, 2025 conference call?

Dial 1-800-715-9871 (US/Canada toll-free) or 1-646-307-1963 (international) and use conference ID 7974705.

Where can I listen to the Vireo Growth (VREOF) Q3 2025 webcast?

A live audio webcast will be available in the company's Investor Relations Events & Presentations section and at https://events.q4inc.com/attendee/235390523.

Will Vireo Growth (VREOF) management discuss guidance on the November 12, 2025 call?

The company said management will discuss its Q3 results on the call; specific guidance discussion is not detailed in the announcement.

What is the conference ID for Vireo Growth (VREOF) investor call on November 12, 2025?

The conference ID is 7974705.
Vireo Growth Inc

OTC:VREOF

VREOF Rankings

VREOF Latest News

VREOF Latest SEC Filings

VREOF Stock Data

438.51M
762.00M
23.53%
12.66%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Minneapolis